tiprankstipranks
Advertisement

ILOW - ETF AI Analysis

Compare

Top Page

ILOW

AB International Low Volatility Equity ETF (ILOW)

Rating:61Neutral
Price Target:
ILOW, the AB International Low Volatility Equity ETF, has a solid overall rating driven mainly by high-quality healthcare leaders like AstraZeneca and Novartis, which benefit from strong financial performance, positive earnings calls, and promising product pipelines. ASML and Roche also add strength through robust revenue growth and strategic initiatives, though their relatively high valuations and some overbought or bearish technical signals, along with similar concerns for other holdings, keep the fund’s rating from being higher and highlight valuation and technical risk as key factors to watch.
Positive Factors
Steady Recent Performance
The ETF has shown positive performance over the past month, three months, and year-to-date, indicating steady recent gains.
Global Diversification
Holdings spread across many countries, including the UK, Japan, the U.S., and several European and Asian markets, help reduce reliance on any single economy.
Low-Volatility Focus with Solid Leaders
Top holdings include several well-established companies, some of which have delivered strong year-to-date results, supporting the fund’s low-volatility strategy.
Negative Factors
Above-Average Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can gradually eat into long-term returns.
Country Concentration in the UK
A large share of the portfolio is invested in UK companies, which increases exposure to risks specific to that market.
Mixed Performance Among Top Holdings
Some of the largest positions have shown weak or negative year-to-date performance, which can drag on overall fund returns.

ILOW vs. SPDR S&P 500 ETF (SPY)

ILOW Summary

ILOW is the AB International Low Volatility Equity ETF, which invests in a wide mix of stocks from countries like the UK, Japan, and Europe, aiming for smoother ups and downs than the overall market. It doesn’t track a specific index, but follows a theme of picking international companies that have shown more stable price movements. Well-known holdings include AstraZeneca and SAP. Someone might invest in ILOW to get broad global diversification with a focus on stability rather than big swings. A key risk is that it can still lose value and will move up and down with global stock markets.
How much will it cost me?The AB International Low Volatility Equity ETF (ILOW) has an expense ratio of 0.5%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it uses an actively managed strategy to select stocks with lower volatility, which requires more research and management compared to passively managed funds. It’s designed for investors seeking stability in international markets.
What would affect this ETF?The AB International Low Volatility Equity ETF (ILOW) could benefit from global economic stability and growth, particularly in sectors like financials, technology, and healthcare, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, geopolitical tensions, or regulatory changes in the international markets where it operates, potentially impacting its broad-based exposure and top holdings like SAP SE and Shell. Its focus on low-volatility stocks may help mitigate risks during market downturns but could limit returns in high-growth periods.

ILOW Top 10 Holdings

ILOW’s story is about steady, low-drama growth driven by a global mix of defensive and financial names outside the U.S. BAE Systems has been one of the fund’s quiet engines, rising over the past few months, while Euronext and OCBC are also pulling their weight with solid, steady gains. On the flip side, Schneider Electric and AstraZeneca have been more mixed lately, losing a bit of steam in the short term. With notable exposure to financials, industrials, and staples, the ETF leans on resilience rather than high-flying momentum.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
BAE Systems2.29%$37.12M£66.60B50.45%
61
Neutral
Schneider Electric2.02%$32.73M€131.37B23.47%
62
Neutral
AstraZeneca2.01%$32.53M$311.06B44.19%
80
Outperform
ASML Holding NV1.95%$31.54M€425.45B94.11%
76
Outperform
Tesco plc1.90%$30.74M£30.53B42.38%
74
Outperform
Euronext NV1.86%$30.14M€14.47B8.69%
65
Neutral
OCBC1.83%$29.66MS$100.22B57.49%
71
Outperform
Roche Holding AG1.79%$29.04M$314.74B34.95%
73
Outperform
Novartis AG1.79%$28.91MCHF218.71B35.15%
80
Outperform
Open House Co1.73%$28.08M$7.52B59.04%

ILOW Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
43.75
Negative
100DMA
42.98
Positive
200DMA
42.12
Positive
Market Momentum
MACD
-0.30
Negative
RSI
52.96
Neutral
STOCH
88.80
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ILOW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 42.59, equal to the 50-day MA of 43.75, and equal to the 200-day MA of 42.12, indicating a neutral trend. The MACD of -0.30 indicates Negative momentum. The RSI at 52.96 is Neutral, neither overbought nor oversold. The STOCH value of 88.80 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ILOW.

ILOW Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.66B0.50%
61
Neutral
$1.52B0.54%
62
Neutral
$1.08B0.85%
62
Neutral
$1.04B0.65%
67
Neutral
$961.75M0.45%
64
Neutral
$925.77M0.59%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ILOW
AB International Low Volatility Equity ETF
43.16
7.87
22.30%
CGIC
Capital Group International Core Equity ETF
WCMI
First Trust WCM International Equity ETF
IDVO
Amplify International Enhanced Dividend Income ETF
APIE
ActivePassive International Equity ETF
MFSI
MFS Active International ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement